NCT06177418 Transumbilical Laparoscopic Appendectomy
| NCT ID | NCT06177418 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Necmi Kadıoğlu Hospital |
| Condition | Appendicitis |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-12-25 |
| Primary Completion | 2024-09-29 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2023-12-25 with a primary completion date of 2024-09-29.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Transumbilical laparoscopic appendectomy (TULA) is increasingly favored in the treatment of appendicitis within the realm of minimally invasive surgical approaches. This procedure offers advantages such as superior cosmetic outcomes and reduced postoperative pain. However, like all surgical interventions, it carries the inherent risk of surgical site infections (SSI), which pose significant challenges to patient health and healthcare systems by escalating treatment costs, prolonging recovery, and increasing morbidity rates. This study aims to evaluate the efficacy of the "glove finger method" in mitigating SSI risk in TULA. The rationale for this study is predicated on the hypothesis that the glove finger method could serve as a simple and cost-effective measure offering potential protection against SSIs. When compared to traditional methods, this technique may not only reduce surgical duration but also diminish the risk of SSIs, thereby potentially decreasing hospital stay durations. Furthermore, enhancing the understanding of factors contributing to the development of SSIs and developing effective strategies for their prevention can elevate patient care quality and alleviate the burden on healthcare systems.
Eligibility Criteria
Inclusion Criteria: patients undergo appendectomy between 5 and 18 years. Exclusion Criteria: Comorbidity previous surgery
Frequently Asked Questions
Who can join the NCT06177418 clinical trial?
This trial is open to participants of all sexes, aged 5 Years or older, up to 18 Years, studying Appendicitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06177418 currently recruiting?
Yes, NCT06177418 is actively recruiting participants. Visit ClinicalTrials.gov or contact Necmi Kadıoğlu Hospital to inquire about joining.
Where is the NCT06177418 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT06177418 clinical trial?
NCT06177418 is sponsored by Necmi Kadıoğlu Hospital. The trial plans to enroll 100 participants.